Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses
BACKGROUND: The routes of transmission of human herpes virus 8 (HHV‐8) remain unclear. In particular, HHV‐8 transmission by blood components and organ transplantation is still debated and raises public health issues. The objective of this study was to determine the prevalence of anti‐HHV‐8 in select...
Gespeichert in:
| Veröffentlicht in: | Transfusion (Philadelphia, Pa.) Pa.), 2001-09, Vol.41 (9), p.1120-1125 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1125 |
|---|---|
| container_issue | 9 |
| container_start_page | 1120 |
| container_title | Transfusion (Philadelphia, Pa.) |
| container_volume | 41 |
| creator | Challine, Dominique Roudot-Thoraval, Françoise Sarah, Turiaf Laperche, Liliane Boisson, Bruno Mauberquez, Stéphanie Dubernet, Fabienne Rigot, Pïerrette Lefrère, François Mercier, Bernard Brossard, Yvon Rouet, François Girot, Robert Loiseau, Pascale Girard, Danièle Claquin, Jacky Loty, Bernard Lerable, Joëlle Mariotti, Martine Pawlotsky, Jean-Michel Lefrère, Jean-Jacques |
| description | BACKGROUND: The routes of transmission of human herpes virus 8 (HHV‐8) remain unclear. In particular, HHV‐8 transmission by blood components and organ transplantation is still debated and raises public health issues. The objective of this study was to determine the prevalence of anti‐HHV‐8 in selected populations of persons or patients with or without risk factors for the transmission of viral infections, in order to determine the routes of HHV‐8 transmission.
STUDY DESIGN AND METHODS: A total of 1431 persons or patients at low or high risk of sexually, blood‐, or graft‐transmitted viral infections were tested by means of a standardized immunofluorescence serologic assay detecting anti‐HHV‐8.
RESULTS: The persons or patients could be classified into three distinct groups according to anti‐HHV‐8 prevalence: a low prevalence group (0.0% to 5.0%), including healthy blood donors, healthy pregnant women, multiply transfused patients with thalassemia major, and IV drug users; an intermediate prevalence group (5.0% to 20.0%), including organ donors, kidney transplant recipients, and multiply transfused patients with sickle cell disease; a high prevalence group (>20.0%), including HIV‐negative persons at high risk of sexually‐transmitted viral infections, and HIV‐infected homosexual men and heterosexuals.
CONCLUSION: The sexual route appears to be the main route of HHV‐8 transmission; bloodborne transmission of HHV‐8, if it exists, is rare. In contrast, organ transplantation recipients might be exposed to HHV‐8 transmission by the transplanted organ, which raises the issue of systematic screening of organ donors. |
| doi_str_mv | 10.1046/j.1537-2995.2001.41091120.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71180771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71180771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4480-d4e0afb9dedf878e84dab6f15de1a10722576036a82ac71491a23042296494723</originalsourceid><addsrcrecordid>eNqVkUFv1DAQhS0EokvhLyBLCE5NmHGcOBGnqqUtogKpFMrN8iaTrrfZONhJu_sb-qdJ2G175mRZ75s3o_cYe4cQI8js4zLGNFGRKIo0FgAYS4QCUUC8fsZmj9pzNgOQGCEmYo-9CmEJAKIAfMn2ENNUQJbP2P0P8q7zdGsaakviruaLYWVaviDfUeC31g-B59y0vZ27asNtyzvXDY3prWsDNz1f2OsFd5437o57G24mj96bNtRDGJkDfu1N3R9MSKD1YJqturJhkif63xIKr9mL2jSB3uzeffbz5PPl0Vl0_v30y9HheVRKmUNUSQJTz4uKqjpXOeWyMvOsxrQiNAhKiFRlkGQmF6ZUKAs0IgEpRJHJQiqR7LMPW9_Ouz8DhV6Pt5TUNKYlNwStEHNQCkfw0xYsvQvBU607b1fGbzSCnrrQSz3lrae89dSFfuhCr8fpt7s1w3xF1dPsLvwReL8DTChNU4-plDY8cRJSVaTJyB1vuTvb0OZ_btCXFycPv9Em2trY0NP60cb4G52pRKX66tuphl9fj-FK_tYXyV9MD7de</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71180771</pqid></control><display><type>article</type><title>Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Challine, Dominique ; Roudot-Thoraval, Françoise ; Sarah, Turiaf ; Laperche, Liliane ; Boisson, Bruno ; Mauberquez, Stéphanie ; Dubernet, Fabienne ; Rigot, Pïerrette ; Lefrère, François ; Mercier, Bernard ; Brossard, Yvon ; Rouet, François ; Girot, Robert ; Loiseau, Pascale ; Girard, Danièle ; Claquin, Jacky ; Loty, Bernard ; Lerable, Joëlle ; Mariotti, Martine ; Pawlotsky, Jean-Michel ; Lefrère, Jean-Jacques</creator><creatorcontrib>Challine, Dominique ; Roudot-Thoraval, Françoise ; Sarah, Turiaf ; Laperche, Liliane ; Boisson, Bruno ; Mauberquez, Stéphanie ; Dubernet, Fabienne ; Rigot, Pïerrette ; Lefrère, François ; Mercier, Bernard ; Brossard, Yvon ; Rouet, François ; Girot, Robert ; Loiseau, Pascale ; Girard, Danièle ; Claquin, Jacky ; Loty, Bernard ; Lerable, Joëlle ; Mariotti, Martine ; Pawlotsky, Jean-Michel ; Lefrère, Jean-Jacques</creatorcontrib><description>BACKGROUND: The routes of transmission of human herpes virus 8 (HHV‐8) remain unclear. In particular, HHV‐8 transmission by blood components and organ transplantation is still debated and raises public health issues. The objective of this study was to determine the prevalence of anti‐HHV‐8 in selected populations of persons or patients with or without risk factors for the transmission of viral infections, in order to determine the routes of HHV‐8 transmission.
STUDY DESIGN AND METHODS: A total of 1431 persons or patients at low or high risk of sexually, blood‐, or graft‐transmitted viral infections were tested by means of a standardized immunofluorescence serologic assay detecting anti‐HHV‐8.
RESULTS: The persons or patients could be classified into three distinct groups according to anti‐HHV‐8 prevalence: a low prevalence group (0.0% to 5.0%), including healthy blood donors, healthy pregnant women, multiply transfused patients with thalassemia major, and IV drug users; an intermediate prevalence group (5.0% to 20.0%), including organ donors, kidney transplant recipients, and multiply transfused patients with sickle cell disease; a high prevalence group (>20.0%), including HIV‐negative persons at high risk of sexually‐transmitted viral infections, and HIV‐infected homosexual men and heterosexuals.
CONCLUSION: The sexual route appears to be the main route of HHV‐8 transmission; bloodborne transmission of HHV‐8, if it exists, is rare. In contrast, organ transplantation recipients might be exposed to HHV‐8 transmission by the transplanted organ, which raises the issue of systematic screening of organ donors.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1046/j.1537-2995.2001.41091120.x</identifier><identifier>PMID: 11552068</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Inc</publisher><subject>Adult ; Antibodies, Viral - analysis ; Biological and medical sciences ; Blood Transfusion ; Female ; Herpesviridae Infections - transmission ; Herpesvirus 8, Human - immunology ; HHV-8 = human herpes virus 8 ; Human viral diseases ; Humans ; IFA(s) = immunofluorescence assay(s) ; Infectious diseases ; IVDU(s) = IV drug user(s) ; KS = Kaposi sarcoma ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Organ Transplantation ; Risk Factors ; Seroepidemiologic Studies ; Sexual Behavior ; Tissue Donors ; Viral diseases</subject><ispartof>Transfusion (Philadelphia, Pa.), 2001-09, Vol.41 (9), p.1120-1125</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4480-d4e0afb9dedf878e84dab6f15de1a10722576036a82ac71491a23042296494723</citedby><cites>FETCH-LOGICAL-c4480-d4e0afb9dedf878e84dab6f15de1a10722576036a82ac71491a23042296494723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1537-2995.2001.41091120.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1537-2995.2001.41091120.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14057953$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11552068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Challine, Dominique</creatorcontrib><creatorcontrib>Roudot-Thoraval, Françoise</creatorcontrib><creatorcontrib>Sarah, Turiaf</creatorcontrib><creatorcontrib>Laperche, Liliane</creatorcontrib><creatorcontrib>Boisson, Bruno</creatorcontrib><creatorcontrib>Mauberquez, Stéphanie</creatorcontrib><creatorcontrib>Dubernet, Fabienne</creatorcontrib><creatorcontrib>Rigot, Pïerrette</creatorcontrib><creatorcontrib>Lefrère, François</creatorcontrib><creatorcontrib>Mercier, Bernard</creatorcontrib><creatorcontrib>Brossard, Yvon</creatorcontrib><creatorcontrib>Rouet, François</creatorcontrib><creatorcontrib>Girot, Robert</creatorcontrib><creatorcontrib>Loiseau, Pascale</creatorcontrib><creatorcontrib>Girard, Danièle</creatorcontrib><creatorcontrib>Claquin, Jacky</creatorcontrib><creatorcontrib>Loty, Bernard</creatorcontrib><creatorcontrib>Lerable, Joëlle</creatorcontrib><creatorcontrib>Mariotti, Martine</creatorcontrib><creatorcontrib>Pawlotsky, Jean-Michel</creatorcontrib><creatorcontrib>Lefrère, Jean-Jacques</creatorcontrib><title>Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND: The routes of transmission of human herpes virus 8 (HHV‐8) remain unclear. In particular, HHV‐8 transmission by blood components and organ transplantation is still debated and raises public health issues. The objective of this study was to determine the prevalence of anti‐HHV‐8 in selected populations of persons or patients with or without risk factors for the transmission of viral infections, in order to determine the routes of HHV‐8 transmission.
STUDY DESIGN AND METHODS: A total of 1431 persons or patients at low or high risk of sexually, blood‐, or graft‐transmitted viral infections were tested by means of a standardized immunofluorescence serologic assay detecting anti‐HHV‐8.
RESULTS: The persons or patients could be classified into three distinct groups according to anti‐HHV‐8 prevalence: a low prevalence group (0.0% to 5.0%), including healthy blood donors, healthy pregnant women, multiply transfused patients with thalassemia major, and IV drug users; an intermediate prevalence group (5.0% to 20.0%), including organ donors, kidney transplant recipients, and multiply transfused patients with sickle cell disease; a high prevalence group (>20.0%), including HIV‐negative persons at high risk of sexually‐transmitted viral infections, and HIV‐infected homosexual men and heterosexuals.
CONCLUSION: The sexual route appears to be the main route of HHV‐8 transmission; bloodborne transmission of HHV‐8, if it exists, is rare. In contrast, organ transplantation recipients might be exposed to HHV‐8 transmission by the transplanted organ, which raises the issue of systematic screening of organ donors.</description><subject>Adult</subject><subject>Antibodies, Viral - analysis</subject><subject>Biological and medical sciences</subject><subject>Blood Transfusion</subject><subject>Female</subject><subject>Herpesviridae Infections - transmission</subject><subject>Herpesvirus 8, Human - immunology</subject><subject>HHV-8 = human herpes virus 8</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>IFA(s) = immunofluorescence assay(s)</subject><subject>Infectious diseases</subject><subject>IVDU(s) = IV drug user(s)</subject><subject>KS = Kaposi sarcoma</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Organ Transplantation</subject><subject>Risk Factors</subject><subject>Seroepidemiologic Studies</subject><subject>Sexual Behavior</subject><subject>Tissue Donors</subject><subject>Viral diseases</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkUFv1DAQhS0EokvhLyBLCE5NmHGcOBGnqqUtogKpFMrN8iaTrrfZONhJu_sb-qdJ2G175mRZ75s3o_cYe4cQI8js4zLGNFGRKIo0FgAYS4QCUUC8fsZmj9pzNgOQGCEmYo-9CmEJAKIAfMn2ENNUQJbP2P0P8q7zdGsaakviruaLYWVaviDfUeC31g-B59y0vZ27asNtyzvXDY3prWsDNz1f2OsFd5437o57G24mj96bNtRDGJkDfu1N3R9MSKD1YJqturJhkif63xIKr9mL2jSB3uzeffbz5PPl0Vl0_v30y9HheVRKmUNUSQJTz4uKqjpXOeWyMvOsxrQiNAhKiFRlkGQmF6ZUKAs0IgEpRJHJQiqR7LMPW9_Ouz8DhV6Pt5TUNKYlNwStEHNQCkfw0xYsvQvBU607b1fGbzSCnrrQSz3lrae89dSFfuhCr8fpt7s1w3xF1dPsLvwReL8DTChNU4-plDY8cRJSVaTJyB1vuTvb0OZ_btCXFycPv9Em2trY0NP60cb4G52pRKX66tuphl9fj-FK_tYXyV9MD7de</recordid><startdate>200109</startdate><enddate>200109</enddate><creator>Challine, Dominique</creator><creator>Roudot-Thoraval, Françoise</creator><creator>Sarah, Turiaf</creator><creator>Laperche, Liliane</creator><creator>Boisson, Bruno</creator><creator>Mauberquez, Stéphanie</creator><creator>Dubernet, Fabienne</creator><creator>Rigot, Pïerrette</creator><creator>Lefrère, François</creator><creator>Mercier, Bernard</creator><creator>Brossard, Yvon</creator><creator>Rouet, François</creator><creator>Girot, Robert</creator><creator>Loiseau, Pascale</creator><creator>Girard, Danièle</creator><creator>Claquin, Jacky</creator><creator>Loty, Bernard</creator><creator>Lerable, Joëlle</creator><creator>Mariotti, Martine</creator><creator>Pawlotsky, Jean-Michel</creator><creator>Lefrère, Jean-Jacques</creator><general>Blackwell Science Inc</general><general>Blackwell Publishing</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200109</creationdate><title>Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses</title><author>Challine, Dominique ; Roudot-Thoraval, Françoise ; Sarah, Turiaf ; Laperche, Liliane ; Boisson, Bruno ; Mauberquez, Stéphanie ; Dubernet, Fabienne ; Rigot, Pïerrette ; Lefrère, François ; Mercier, Bernard ; Brossard, Yvon ; Rouet, François ; Girot, Robert ; Loiseau, Pascale ; Girard, Danièle ; Claquin, Jacky ; Loty, Bernard ; Lerable, Joëlle ; Mariotti, Martine ; Pawlotsky, Jean-Michel ; Lefrère, Jean-Jacques</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4480-d4e0afb9dedf878e84dab6f15de1a10722576036a82ac71491a23042296494723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Antibodies, Viral - analysis</topic><topic>Biological and medical sciences</topic><topic>Blood Transfusion</topic><topic>Female</topic><topic>Herpesviridae Infections - transmission</topic><topic>Herpesvirus 8, Human - immunology</topic><topic>HHV-8 = human herpes virus 8</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>IFA(s) = immunofluorescence assay(s)</topic><topic>Infectious diseases</topic><topic>IVDU(s) = IV drug user(s)</topic><topic>KS = Kaposi sarcoma</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Organ Transplantation</topic><topic>Risk Factors</topic><topic>Seroepidemiologic Studies</topic><topic>Sexual Behavior</topic><topic>Tissue Donors</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Challine, Dominique</creatorcontrib><creatorcontrib>Roudot-Thoraval, Françoise</creatorcontrib><creatorcontrib>Sarah, Turiaf</creatorcontrib><creatorcontrib>Laperche, Liliane</creatorcontrib><creatorcontrib>Boisson, Bruno</creatorcontrib><creatorcontrib>Mauberquez, Stéphanie</creatorcontrib><creatorcontrib>Dubernet, Fabienne</creatorcontrib><creatorcontrib>Rigot, Pïerrette</creatorcontrib><creatorcontrib>Lefrère, François</creatorcontrib><creatorcontrib>Mercier, Bernard</creatorcontrib><creatorcontrib>Brossard, Yvon</creatorcontrib><creatorcontrib>Rouet, François</creatorcontrib><creatorcontrib>Girot, Robert</creatorcontrib><creatorcontrib>Loiseau, Pascale</creatorcontrib><creatorcontrib>Girard, Danièle</creatorcontrib><creatorcontrib>Claquin, Jacky</creatorcontrib><creatorcontrib>Loty, Bernard</creatorcontrib><creatorcontrib>Lerable, Joëlle</creatorcontrib><creatorcontrib>Mariotti, Martine</creatorcontrib><creatorcontrib>Pawlotsky, Jean-Michel</creatorcontrib><creatorcontrib>Lefrère, Jean-Jacques</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Challine, Dominique</au><au>Roudot-Thoraval, Françoise</au><au>Sarah, Turiaf</au><au>Laperche, Liliane</au><au>Boisson, Bruno</au><au>Mauberquez, Stéphanie</au><au>Dubernet, Fabienne</au><au>Rigot, Pïerrette</au><au>Lefrère, François</au><au>Mercier, Bernard</au><au>Brossard, Yvon</au><au>Rouet, François</au><au>Girot, Robert</au><au>Loiseau, Pascale</au><au>Girard, Danièle</au><au>Claquin, Jacky</au><au>Loty, Bernard</au><au>Lerable, Joëlle</au><au>Mariotti, Martine</au><au>Pawlotsky, Jean-Michel</au><au>Lefrère, Jean-Jacques</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2001-09</date><risdate>2001</risdate><volume>41</volume><issue>9</issue><spage>1120</spage><epage>1125</epage><pages>1120-1125</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND: The routes of transmission of human herpes virus 8 (HHV‐8) remain unclear. In particular, HHV‐8 transmission by blood components and organ transplantation is still debated and raises public health issues. The objective of this study was to determine the prevalence of anti‐HHV‐8 in selected populations of persons or patients with or without risk factors for the transmission of viral infections, in order to determine the routes of HHV‐8 transmission.
STUDY DESIGN AND METHODS: A total of 1431 persons or patients at low or high risk of sexually, blood‐, or graft‐transmitted viral infections were tested by means of a standardized immunofluorescence serologic assay detecting anti‐HHV‐8.
RESULTS: The persons or patients could be classified into three distinct groups according to anti‐HHV‐8 prevalence: a low prevalence group (0.0% to 5.0%), including healthy blood donors, healthy pregnant women, multiply transfused patients with thalassemia major, and IV drug users; an intermediate prevalence group (5.0% to 20.0%), including organ donors, kidney transplant recipients, and multiply transfused patients with sickle cell disease; a high prevalence group (>20.0%), including HIV‐negative persons at high risk of sexually‐transmitted viral infections, and HIV‐infected homosexual men and heterosexuals.
CONCLUSION: The sexual route appears to be the main route of HHV‐8 transmission; bloodborne transmission of HHV‐8, if it exists, is rare. In contrast, organ transplantation recipients might be exposed to HHV‐8 transmission by the transplanted organ, which raises the issue of systematic screening of organ donors.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Inc</pub><pmid>11552068</pmid><doi>10.1046/j.1537-2995.2001.41091120.x</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1132 |
| ispartof | Transfusion (Philadelphia, Pa.), 2001-09, Vol.41 (9), p.1120-1125 |
| issn | 0041-1132 1537-2995 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71180771 |
| source | MEDLINE; Wiley Online Library Journals |
| subjects | Adult Antibodies, Viral - analysis Biological and medical sciences Blood Transfusion Female Herpesviridae Infections - transmission Herpesvirus 8, Human - immunology HHV-8 = human herpes virus 8 Human viral diseases Humans IFA(s) = immunofluorescence assay(s) Infectious diseases IVDU(s) = IV drug user(s) KS = Kaposi sarcoma Male Medical sciences Middle Aged Miscellaneous Organ Transplantation Risk Factors Seroepidemiologic Studies Sexual Behavior Tissue Donors Viral diseases |
| title | Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T14%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroprevalence%20of%20human%20herpes%20virus%208%20antibody%20in%20populations%20at%20high%20or%20low%20risk%20of%20transfusion,%20graft,%20or%20sexual%20transmission%20of%20viruses&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Challine,%20Dominique&rft.date=2001-09&rft.volume=41&rft.issue=9&rft.spage=1120&rft.epage=1125&rft.pages=1120-1125&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1046/j.1537-2995.2001.41091120.x&rft_dat=%3Cproquest_cross%3E71180771%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71180771&rft_id=info:pmid/11552068&rfr_iscdi=true |